Loading...
Loading...
Below are the top small-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of PEG ratio.
DepoMed
DEPO has a PEG ratio of 0.37. DepoMed's trailing-twelve-month revenue is $222.30 million.
SciClone Pharmaceuticals
SCLN has a PEG ratio of 1.17. SciClone Pharma's trailing-twelve-month EPS is $0.42
Lannett Company
LCI has a PEG ratio of 1.61. Lannett's trailing-twelve-month ROE is 21.70%.
Sucampo Pharmaceuticals
SCMP has a PEG ratio of 4.32. Sucampo Pharma's trailing-twelve-month operating margin is 8.90%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in